ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Sold by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. lessened its stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 1.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,251,332 shares of the biopharmaceutical company’s stock after selling 19,803 shares during the period. Charles Schwab Investment […]
